Coverage
Filings
Genmab A/S announced encouraging results from its Phase 1/2 RAINFOL-01 trial for rinatabart sesutecan (Rina-S), an investigational antibody-drug conjugate (ADC), in heavily pretreated patients with advanced endometrial cancer.
| 1 Jul 2003 |
| Genmab, Genmab Files CTA for HuMax-EGFr to Treat Cancer | 27 Jun 2003 |
| Genmab, Genmab's HuMax-CD20 Cancer Antibody Shows Promising Results in Primate Study | 26 Jun 2003 |
| Genmab, Grant of Warrants in Genmab A/S | 25 Jun 2003 |
| Genmab, quarterly statement of shareholdings | 18 Jun 2003 |